These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 17920818)

  • 41. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y; Nishie W; Izumi K; Shimizu H
    Front Immunol; 2019; 10():1224. PubMed ID: 31191560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
    Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
    J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.
    Messingham KA; Noe MH; Chapman MA; Giudice GJ; Fairley JA
    J Immunol Methods; 2009 Jul; 346(1-2):18-25. PubMed ID: 19422829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study.
    Di Zenzo G; Thoma-Uszynski S; Calabresi V; Fontao L; Hofmann SC; Lacour JP; Sera F; Bruckner-Tuderman L; Zambruno G; Borradori L; Hertl M
    J Invest Dermatol; 2011 Nov; 131(11):2271-80. PubMed ID: 21697892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoglobulin E and bullous pemphigoid.
    Cozzani E; Gasparini G; Di Zenzo G; Parodi A
    Eur J Dermatol; 2018 Aug; 28(4):440-448. PubMed ID: 30325326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of pemphigoid gestationis with concurrent IgG antibodies to BP180, BP230 and type VII collagen.
    Yang B; Wang C; Wu M; Du D; Yan X; Zhou G; Zhang F
    Australas J Dermatol; 2014 Feb; 55(1):e15-8. PubMed ID: 23082779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230.
    Kiss M; Husz S; Jánossy T; Marczinovits I; Molnár J; Korom I; Dobozy A
    J Autoimmun; 2005 Feb; 24(1):1-10. PubMed ID: 15725571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
    Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
    Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?
    Schmidt T; Sitaru C; Amber K; Hertl M
    Br J Dermatol; 2014 Aug; 171(2):212-9. PubMed ID: 24601973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
    Desai N; Allen J; Ali I; Venning V; Wojnarowska F
    Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
    Chan LS
    Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
    [No Abstract]   [Full Text] [Related]  

  • 52. Bullous pemphigoid: from the clinic to the bench.
    Di Zenzo G; Della Torre R; Zambruno G; Borradori L
    Clin Dermatol; 2012; 30(1):3-16. PubMed ID: 22137222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
    Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
    Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
    Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
    Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid.
    Delaporte E; Dubost-Brama A; Ghohestani R; Nicolas JF; Neyrinck JL; Bergoend H; Janin A; Capron M
    J Immunol; 1996 Oct; 157(8):3642-7. PubMed ID: 8871665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
    Metz BJ; Ruggeri SY; Hsu S; Reed JA; Ghohestani AS; Uitto J; Ghohestani RF
    Int J Dermatol; 2004 Jun; 43(6):443-6. PubMed ID: 15186228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated levels of circulating immunoglobulin E autoantibodies against BP180 and BP230 in an intractable case of bullous pemphigoid.
    Akasaka E; Hagiwara C; Takiyoshi N; Aizu T; Nakano H; Sawamura D; Ota T
    J Dermatol Sci; 2016 Oct; 84(1):110-113. PubMed ID: 27492811
    [No Abstract]   [Full Text] [Related]  

  • 60. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
    Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
    Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.